ACXP News and Press, Acurx Pharmaceuticals Inc. From 10/27/25

Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update PR Newswire STATEN ISLAND, N.Y. , Oct. 27, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late...

Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors PR Newswire STATEN ISLAND, N.Y. , Oct. 9, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company devel...

A look at the top 10 most actives in the United States Nuburu Inc. (BURU) rose 37.7% to $0.6541 on volume of 1,115,347,829 shares AiRWA Inc. (YYAI) rose 7.2% to $0.193 on volume of 1,028,945,655 shares Adaptimmune Therapeutics plc (ADAP) rose 51.9% to $0.2105 on volume of 489,215,087 shares...

2025-10-08 10:02:24 ET DENVER, Colo., Oct 08, 2025 ( 247marketnews.com )- VENU (NYSE:VENU) reported that its Luxe FireSuites have generated over $23 million in demand over the past 60 days alone, $10.7 million in August and $12.3 million in September, marking a record pace i...

A look at the top 10 most actives in the United States Nuburu Inc. (BURU) rose 61.8% to $0.7684 on volume of 327,892,648 shares AiRWA Inc. (YYAI) rose 69.9% to $0.3058 on volume of 234,901,612 shares Nexalin Technology Inc. (NXL) rose 79.1% to $1.6801 on volume of 81,643,105 shares Proces...

Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection PR Newswire The Paediatric Committee (PDCO) of the European Medicines Agency issued a positive opinion on Acurx's Pediatric Investigation Plan...

2025-09-03 07:42:51 ET More on Acurx Pharmaceuticals Acurx Pharmaceuticals, Inc. (ACXP) Q2 2025 Earnings Call Transcript Acurx signals ongoing cost controls and new trial funding avenues while advancing ibezapolstat clinical program Acurx Pharmaceuticals files $50M m...

2025-08-12 10:14:26 ET More on Acurx Pharmaceuticals Acurx Pharmaceuticals, Inc. (ACXP) Q2 2025 Earnings Call Transcript Acurx Pharmaceuticals files $50M mixed shelf offering Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals Historical earnings dat...

2025-08-12 10:13:48 ET Acurx Pharmaceuticals, Inc. (ACXP) Q2 2025 Earnings Conference Call August 12 2025, 08:00 AM ET Company Participants David P. Luci - Co-Founder, President, CEO, Corporate Secretary & Director Robert G. Shawah - Co-Founder & CFO Co...

2025-08-12 07:10:02 ET More on Acurx Pharmaceuticals Acurx Pharmaceuticals files $50M mixed shelf offering Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals Historical earnings data for Acurx Pharmaceuticals Financial information for Acurx Pharmace...